Multivalvular Disease: Percutaneous Management in 2019 and Beyond
Patients with multivalvular disease (MVD) are common and often present with heterogeneous valve defects. Evaluation is complicated by interactions among various valve pathologies. Trials and guidelines focus primarily on single-valve disease, providing few recommendations for the treatment of patien...
Guardado en:
Autores principales: | , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Radcliffe Medical Media
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/81d87deb3f12433da9dfc3a9365d8cfa |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:81d87deb3f12433da9dfc3a9365d8cfa |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:81d87deb3f12433da9dfc3a9365d8cfa2021-12-04T16:02:04ZMultivalvular Disease: Percutaneous Management in 2019 and Beyond10.15420/icr.2019.13.R11756-14851756-1477https://doaj.org/article/81d87deb3f12433da9dfc3a9365d8cfa2019-11-01T00:00:00Zhttps://www.icrjournal.com/articles/Multivalvular-Disease-Percutaneous-Management-2019https://doaj.org/toc/1756-1477https://doaj.org/toc/1756-1485Patients with multivalvular disease (MVD) are common and often present with heterogeneous valve defects. Evaluation is complicated by interactions among various valve pathologies. Trials and guidelines focus primarily on single-valve disease, providing few recommendations for the treatment of patients with MVD. This article provides an insight into percutaneous treatment possibilities for this heterogeneous patient population.Magdalena ErlebachRüdiger LangeRadcliffe Medical MediaarticleSurgeryRD1-811Diseases of the circulatory (Cardiovascular) systemRC666-701ENInterventional Cardiology: Reviews, Research, Resources, Vol 14, Iss 3, Pp 142-146 (2019) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Surgery RD1-811 Diseases of the circulatory (Cardiovascular) system RC666-701 |
spellingShingle |
Surgery RD1-811 Diseases of the circulatory (Cardiovascular) system RC666-701 Magdalena Erlebach Rüdiger Lange Multivalvular Disease: Percutaneous Management in 2019 and Beyond |
description |
Patients with multivalvular disease (MVD) are common and often present with heterogeneous valve defects. Evaluation is complicated by interactions among various valve pathologies. Trials and guidelines focus primarily on single-valve disease, providing few recommendations for the treatment of patients with MVD. This article provides an insight into percutaneous treatment possibilities for this heterogeneous patient population. |
format |
article |
author |
Magdalena Erlebach Rüdiger Lange |
author_facet |
Magdalena Erlebach Rüdiger Lange |
author_sort |
Magdalena Erlebach |
title |
Multivalvular Disease: Percutaneous Management in 2019 and Beyond |
title_short |
Multivalvular Disease: Percutaneous Management in 2019 and Beyond |
title_full |
Multivalvular Disease: Percutaneous Management in 2019 and Beyond |
title_fullStr |
Multivalvular Disease: Percutaneous Management in 2019 and Beyond |
title_full_unstemmed |
Multivalvular Disease: Percutaneous Management in 2019 and Beyond |
title_sort |
multivalvular disease: percutaneous management in 2019 and beyond |
publisher |
Radcliffe Medical Media |
publishDate |
2019 |
url |
https://doaj.org/article/81d87deb3f12433da9dfc3a9365d8cfa |
work_keys_str_mv |
AT magdalenaerlebach multivalvulardiseasepercutaneousmanagementin2019andbeyond AT rudigerlange multivalvulardiseasepercutaneousmanagementin2019andbeyond |
_version_ |
1718372745916448768 |